This message was sent to ##Email##
|
|
|
As 2016 comes to a close, ACS would like to wish its members, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of The Brief a look at the 20 most accessed articles from the year. Here is Part 1. Our regular publication will resume Wednesday, Jan. 4.
|
NCCRT
From Aug. 10: Eighty percent by 2018 is a National Colorectal Cancer Roundtable initiative through which more than 1,000 organizations have joined in the commitment to reducing colorectal cancer as a major public health problem. The organizations are working together toward the shared goal of reaching 80 percent of age-appropriate adults being regularly screened for colorectal cancer by 2018. The National Colorectal Cancer Roundtable worked in collaboration with the American College of Gastroenterology, the American College of Surgeons (ACS) Commission on Cancer (CoC), the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy to develop a helpful resource for Endoscopists titled What Can Gastroenterologists and Endoscopists Do to Advance 80 Percent by 2018? Check out this resource to see what you can do to impact this important effort to make the 80 percent colorectal cancer screening rate by 2018 a reality.
READ MORE
Promoted by
|
|
|
 |
ACS
From Aug. 17: The American College of Surgeons (ACS) has issued a statement on proper dress for surgeons, whether in the operating room or interacting with families or the public outside.
ACS Executive Director David B. Hoyt, M.D., said the refresher statement is meant to provide evidence-based consensus on appropriate head coverings and when scrubs must be changed.
READ MORE
Medical Xpress
From July 20: The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, reports a new Northwestern Medicine study. The report considers whether a recent trend of fewer men being screened may be contributing to the rise, or whether the disease has become more aggressive — or both. The largest increase in new cases was among men 55 to 69 years old, which rose 92 percent in the past decade.
READ MORE
|
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text.
|
|
Cancer Therapy Advisor
From Jan. 6: Oncologists now have a tool for helping the growing numbers of cancer survivors in the United States. The American Society for Radiation Oncology published a new template that standardizes and streamlines the creation of patient-focused plans for long-term cancer survivor care following radiation therapy.
READ MORE
The Wall Street Journal
From May 11: When Al Piazza learned he had prostate cancer, his first thought was, "Let's get this out and be done with it," he says. But his urologist, Jeremy Lieb, said the side effects of treatment could be more harmful than the cancer itself.
Dr. Lieb ran a genetic test on the patient's biopsy sample, which calculated that Piazza, then 70 years old, had only a 3 percent chance of dying from prostate cancer over the next 10 years if he left the tumor untreated.
Four years later, the retired AT&T manager from Discovery Bay, California, has been monitoring his cancer with regular blood tests and imaging scans and says he is comfortable leaving it alone.
READ MORE
Promoted by
|
|
|
 |
MobiHealthNews
From May 4: Dana Farber Cancer Institute has partnered with Fitbit to launch a two-year randomized study that will investigate the impact of weight loss on breast cancer recurrence. The study, called the Breast Cancer Weight Loss study, is sponsored by the National Cancer Institute and the Alliance for Clinical Trials in Oncology.
READ MORE
The Washington Post
From April 20: New immunotherapy drugs are showing significant and extended effectiveness against a broadening range of cancers, including rare and intractable tumors often caused by viruses. Researchers say these advances suggest the treatment approach is poised to become a critical part of the nation's anti-cancer strategy.
READ MORE
 |
|
prIME Patients is prIME Oncology’s resource center for patients with cancer and their caregivers. Our patient-focused videos explain, in layman’s terms, how certain treatments fight the various cancers. This information will arm you with the knowledge on what to expect during your course treatment so that you can be an informed part of the decision making team.
|
|
AJMC
From June 22: Healthcare is rapidly transitioning from a fee-for-service to a value-based reimbursement world. This transition accelerated when, in January 2015, HHS announced a new set of goals and a timeline for tying Medicare payments to quality or value through alternative payment models.
READ MORE
|
|
|
|
|
Care2
From July 27: New research examining advanced prostate cancer in the U.S. finds that cases may have risen 72 percent in the past decade. But is this idea a true reflection of what's occurring?
The research, conducted by a team at Northwestern University and published recently in the journal Prostate Cancer and Prostatic Diseases, analyzes data from the National Cancer Database, a registry supported by the American College of Surgeons and the American Cancer society. The data sample in this case included more than 700,000 men who had been diagnosed with prostate cancer between 2004 and 2013.
READ MORE
Modern Healthcare
From Feb. 17: In 2014, the University of California at San Francisco Hospital performed 237 surgeries for prostate cancer. Less than three miles away, the Kaiser Foundation Hospital performed 30 such procedures. And four miles south, San Francisco General Hospital performed just six.
Radical prostatectomy is a common treatment for early stage prostate cancer. But as many as 24 percent of hospitals in California performed only one or two of these surgeries that year.
READ MORE
|
|
|
| The Brief
Connect with AJCC

Connect with CoC

Connect with NAPBC

Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Whipple, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC.
American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|